Corcept Therapeutics Incorporated
CORT
Xếp hạng trong cổ phiếu
#1693
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo... Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for adult patients diagnosed with endogenous Cushing's syndrome who suffer from hyperglycemia due to hypercortisolism, particularly those with type 2 diabetes or glucose intolerance, and for whom surgical options have either failed or are not viable. The company's development pipeline is robust, featuring relacorilant, which is being advanced for Cushing's syndrome. It is also investigating a combination of relacorilant with nab-paclitaxel; this pairing has concluded Phase II clinical trials for advanced ovarian tumors and is additionally being studied for conditions involving cortisol excess. Furthermore, Corcept is developing distinct selective cortisol modulators for specific indications such as metastatic castration-resistant prostate cancer and antipsychotic-induced weight gain, alongside research into FKBP5 gene expression assays.
Giá cổ phiếu
$116.39
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$12.58B
Thay đổi (1 ngày)
-0.05%
Thay đổi (1 năm)
58.03%
Quốc gia
US
Giao dịch Corcept Therapeutics Incorporated (CORT)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Corcept Therapeutics Incorporated (CORT)
Giá đóng cửa cao nhất: $116.99 vào 2026-10-01
Giá đóng cửa thấp nhất: $11.30 vào 2004-04-01
Giá đóng cửa thấp nhất: $11.30 vào 2004-04-01
Lịch sử giá cổ phiếu của Corcept Therapeutics Incorporated từ 2004 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | -9.40% |
| 2025 | 45.40% |
| 2024 | 87.74% |
| 2023 | 37.96% |
| 2022 | 8.70% |
| 2021 | -22.54% |
| 2020 | 97.11% |
| 2019 | -8.02% |
| 2018 | -18.04% |
| 2017 | 113.00% |
| 2016 | 61.25% |
| 2015 | 59.73% |
| 2014 | 23.32% |
| 2013 | 64.30% |
| 2012 | -54.17% |
| 2011 | -17.98% |
| 2010 | 63.22% |
| 2009 | 127.09% |
| 2008 | -61.78% |
| 2007 | 209.70% |
| 2006 | -77.05% |
| 2005 | -25.76% |
| 2004 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $62.20 | 68.82% |
US
|
|
| $46.29 | 37.83% |
SE
|
|
| $171.04 | 23.67% |
FR
|
|
| $59.46 | -0.57% |
IT
|
|
| $0.65 | -30.33% |
HK
|
